| ²é¿´: 658 | »Ø¸´: 0 | |||
¿ÆÑйËÎÊ_Guгæ (СÓÐÃûÆø)
|
[½»Á÷]
¸É»õ·ÖÏí | ´øÄã¿ìËÙÈëÃÅJAK/STAT signaling pathwaysÐźÅͨ·
|
|
Janus¼¤Ã¸£¨JAK£©ÐźÅתµ¼ºÍת¼¼¤»îÒò×Ó£¨JAK-STAT£©Í¾¾¶ÊÇÒ»ÖÖ½ø»¯Éϱ£ÊصÄÐźÅͨ·£¬ÓÉϸ°ûÒò×Ӵ̼¤¼¤»î£¬Ê¹Ï¸°ûÍâÐźÅͨ¹ýϸ°ûĤ´«µÝµ½Ï¸°ûºË£¬ÒýÆðDNAת¼µÄ¸Ä±ä£¬ÔÚ¼¸¸ö¹Ø¼üµÄÉúÀí¹ý³ÌÖз¢»Ó×÷Ó㬰üÀ¨ÔìѪ¡¢·Ö»¯¡¢´úлºÍÃâÒßµ÷½Ú¡£ÔڽṹÉÏ£¬JAK-STAT;¾¶Éæ¼°¿çĤÊÜÌå¡¢ÊÜÌåÏà¹ØµÄ°ûÖÊÀÒ°±Ëἤø£¨¼´JAK£©ÒÔ¼°ÐźÅתµ¼ºÍת¼¼¤»îÒò×Ó£¨¼´STATs£©¡£JAKµ°°×¼Ò×å°üº¬Ëĸö³ÉÔ±£ºJAK1¡¢JAK2¡¢JAK3ºÍTYK2¡£STAT¼Ò×åÓɯߏöµ°°×ÖÊ×é³É£ºSTAT1¡¢STAT2¡¢STAT3¡¢STAT4¡¢STAT5A¡¢STAT5BºÍSTAT6¡£ JAK - STATÐźÅͨ·×îÔçÊÇÔÚ¸ÉÈÅËØÏà¹ØµÄת¼¼¤»îÑо¿Öз¢Ïֵġ£Ëæºó£¬ÔÚ´óÔ¼20ÄêµÄʱ¼äÀJAK - STATÐźÅͨ·µÄ×é³ÉºÍ·¢²¡»úÖÆµÄ´óÖÂÂÖÀªÖð½¥Íê³É¡£³¬¹ý50ÖÖϸ°ûÒò×Ó£¬°üÀ¨¸ÉÈÅËØ( IFNs )¡¢°×ϸ°û½éËØ( ILs )ºÍÉú³¤Òò×Ó£¬Òѱ»Ö¤Ã÷ÔÚJAK - STATÐźŴ«µ¼Öз¢»Ó×÷Óã¬ÒÔʵÏÖϸ°û·Ö»¯¡¢´úл¡¢´æ»î¡¢ÎÈ̬ºÍÃâÒß·´Ó¦µÄµ÷½Ú¹¦ÄÜ¡£Ò»µ©ÊÜÌåÓëϸ°ûÍâÅäÌå½áºÏ£¬JAKs¾Í»áÆô¶¯ÊÜÌåµÄÀÒ°±ËáÁ×Ëữ²¢ÕÐļÏàÓ¦µÄSTATs¡£Á×ËữµÄSTATsËæºó¶þ¾Û»¯²¢½øÈëϸ°ûºËµ÷½ÚÌØ¶¨»ùÒòµÄת¼¡£ÕâÒ»¹ý³ÌÄܹ»Ê¹Íâ½çÐźſìËÙ´«µÝµ½Ï¸°ûºË£¬´Ó¶øµ÷½ÚÉúÎïºÍ²¡Àí¹ý³Ì¡£ 01¡¢THE JAK-STAT FAMILY ·ÇÊÜÌåÐÍÀÒ°±ËἤøJAK¼Ò×åÓÉ4¸öµ°°××é³É£ºJAK1¡¢JAK2¡¢JAK3ºÍTYK2¡£Ã¿¸ö¼¤Ã¸×÷Ϊϸ°ûÒò×ÓÐźŴ«µ¼µÄϸ°ûÄÚ½ÓÍ·µ°°×·¢»Ó×÷Óá£JAK3Ö÷ÒªÔÚÔìѪϸ°ûÖи߱í´ï£¬¶øÆäËû³ÉÔ±ÔÚÐí¶à×éÖ¯Öй㷺±í´ï JAKµ°°×ÓÉFERM¡¢SrcͬԴ½á¹¹Óò( SH2 )¡¢¼Ù¼¤Ã¸ºÍ¼¤Ã¸½á¹¹Óò×é³É¡£FERM½á¹¹Óò¾ßÓÐÓÉF1¡¢F2ºÍF3Ñǽṹ×é³ÉµÄÈýÒ¶²Ý½á¹¹¡£FERMºÍSH2½á¹¹ÓòÖ÷Òª¸ºÔðJAKÓëÊÜÌåµÄ½áºÏ¡£¼Ù¼¤Ã¸½á¹¹Óòµ÷½Ú¼¤Ã¸½á¹¹ÓòµÄ»îÐÔ£¬Õâ¶ÔÓÚÊÜÌåÀÒ°±ËáµÄÁ×ËữÊDZز»¿ÉÉٵ쬴Ӷøµ¼ÖÂÏÂÓηÖ×ӵĽøÒ»²½Á×Ëữ¡£Ëĸö½á¹¹Óò¿ÉÒÔ½øÒ»²½·ÖΪÆß¸ö·ÖÇø£¬³ÆÎªJH1 - 7¡£ STATµ°°×ÊÇJAKÏÂÓεÄÐźŷÖ×Ó¡£STAT¼Ò×å³ÉÔ±°üÀ¨STAT1¡¢STAT2¡¢STAT3¡¢STAT4¡¢STAT5A¡¢STAT5BºÍSTAT6¡£STATsÓÉN¶Ë½á¹¹ÓòºÍ¾íÇú¡¢ÂÝÐý½á¹¹Óò¡¢DNA½áºÏ½á¹¹Óò¡¢Á¬½Ó½á¹¹Óò¡¢SH2½á¹¹ÓòºÍת¼¼¤»î½á¹¹Óò×é³É¡£µ±ÊÜÌåÀÒ°±Ëá±»Á×Ëữºó£¬°û½¬ÖеÄSTATs±»ÕÐļµ½»î»¯µÄÊÜÌåÉÏ£¬Ò»¸öSTATÀÒ°±Ëá±»Á×Ëữ£¬µ¼ÖÂSTAT¶þ¾ÛÌåµÄÐγɡ£STAT¶þ¾ÛÌåËæºó×÷Ϊת¼Òò×Ó¸´ºÏÎïµÄ×é·Ö½øÈëϸ°ûºË£¬´Ù½øÌض¨°Ð»ùÒòµÄת¼£¬È»ºóSTATsÔÚϸ°ûºËÖÐÈ¥Á×Ëữ²¢·µ»ØÏ¸°ûÖÊ¡£ÔÚSTAT¼Ò×åÖУ¬STAT3±»ÈÏΪÔÚ´ÓÖÊĤµ½Ï¸°ûºËµÄÐźŴ«µÝÖÐÆðןËÐÄ×÷Óã¬Ê¹Æä³ÉΪҩÎ↑·¢µÄÒ»¸öÓÐǰ;µÄ°Ðµã¡£ 02¡¢JAK¼Ò×幦ÄÜ 03¡¢»î»¯µÄSTAT¼Ò×åÉúÎïѧ¹¦ÄÜ 04¡¢JAK/STATÐźÅͨ·µÄ¼¤»îºÍ¸ºµ÷¿Ø AK/STATͨ·µÄ¼¤»î£º( 1 )ϸ°ûÒò×ÓºÍÉú³¤Òò×ÓÓëÆäÏàÓ¦µÄÊÜÌå½áºÏ£¬µ¼ÖÂÊÜÌå¶þ¾Û»¯£¬ÕÐļÏà¹ØµÄJAKs£»( 2 ) JAKµÄ¼¤»îµ¼ÖÂÊÜÌåÀÒ°±ËáÁ×Ëữ£¬ÐγÉSTATµÄ½áºÏλµã£»( 3 ) STATs±»ÀÒ°±ËáÁ×Ëữ£»( 4 ) STATsÓëÊÜÌå½âÀëÐγÉͬԴ»òÒìÔ´¶þ¾ÛÌ壻( 5 ) STAT¶þ¾ÛÌå½øÈëϸ°ûºË£¬ÓëDNA½áºÏ£¬µ÷¿Ø×ªÂ¼¡£ÒÔÏÂͼÖУ¬ºÚÉ«¼ýÍ·±íʾ¼¤»î¹ý³Ì¡£ºìÉ«ÐéÏß¼ýÍ·±íʾ¸ºµ÷¿Ø ¡£ CIS / SOCS¼Ò×åͨ¹ýÈýÖÖ·½Ê½¶ÔJAK/STAT;¾¶½øÐиºµ÷¿Ø£º( 1 )ÓëÀÒ°±ËἤøÊÜÌå½áºÏ£¬×è¶ÏSTATµÄ=£»( 2 )Ö±½ÓÓëJAK½áºÏ£¬ÒÖÖÆÆä¼¤Ã¸»îÐÔ£»( 3 )ÐγÉelongin B / C - cullin5¸´ºÏÎͨ¹ý¶à¾Û·ºËØ»¯ºÍµ°°×øÌå½µ½âÓëSOCSµ°°×½áºÏµÄJAK»òSTAT¡£ PTPsͨ¹ýÓëJAK¡¢STAT»òÊÜÌåÏ໥×÷Óã¬( 1 )ʹSTAT¶þ¾ÛÌåÈ¥Á×Ëữ£¬´Ó¶øÒÖÖÆJAK/STAT;¾¶£»( 2 )ÓëÊÜÌåÏ໥×÷Óã¬Ê¹Ïà¹ØµÄJAKÈ¥Á×Ëữ£»( 3 )ÔÚCD45 (Ò»¸ö¿çĤµÄPTP)µÄÇé¿öÏ£¬ÒÖÖÆJAKµÄÁ×Ëữ¡£ÓÉBiorender . com´´½¨¡£ 05¡¢Jak - STATͨ·¡¢ÃâÒßµ÷½ÚºÍÆ×ϵ¿ÉËÜÐÔ ´óÁ¿Ï¸°ûÒò×ÓÓëJAK - STATͨ·Ï໥×÷Óã¬Ó°ÏìÃâÒßϸ°û·Ö»¯·¢Óý£¬·¢»ÓÃâÒßµ÷½Ú×÷Óá£IFNºÍIL - 12¶ÔTh1ϸ°û·Ö»¯ÖÁ¹ØÖØÒª£¬·Ö±ðͨ¹ýSTAT1ºÍSTAT4Çý¶¯T - bet»ùÒò±í´ï¡£IL - 4ͨ¹ýSTAT6Éϵ÷GATA3»ùÒò£¬¼¤»îTh2ϸ°û·Ö»¯¡£IL - 6ºÍTGFͨ¹ýSTAT3¼¤»îRORt»ùÒò±í´ï£¬ÔÚTh17ϸ°û·Ö»¯Öз¢»ÓÖØÒª×÷Óá£IL - 6ºÍIL - 12ͨ¹ýSTAT3Ó°ÏìÂËÅݸ¨ÖúÐÔTϸ°ûµÄ·Ö»¯£¬Ôö¼ÓBcl - 6µÄת¼¡£IL - 2ͨ¹ýSTAT5A / BÓëFoxp3»ùÒòÖ±½Ó½áºÏÓÕµ¼Tregϸ°û·Ö»¯¡£ STATs¿ÉÒÔ±»²»Í¬µÄϸ°ûÒò×Ó¼¤»î£¬·´Ö®£¬Ò»¸öϸ°ûÒò×Ó¿ÉÒÔ¼¤»î¶à¸öSTATs¡£²»Í¬µÄϸ°ûÒò×Ó±»¿´×÷ÊDz»Í¬µÄÐźţ¬Ò»¸öÍÆ¶¨µÄ½âÊÍÊDz»Í¬µÄϸ°ûÒò×Ó¼¤»î²»Í¬µÄSTATºÍÆäËûÐźÅÄ£¿éµÄÁ×Ëữˮƽ¡£ÕâÐèÒª¸ü¶àµÄÑо¿À´Ö§³ÖÕâÒ»¼ÙÉè¡£ ²Î¿¼ÎÄÏ×£º [1] HU X, LI J, FU M, et al. The JAK/STAT signaling pathway: from bench to clinic[J/OL]. Signal Transduction and Targeted Therapy, 2021, 6(1): 402. DOI:10.1038/s41392-021-00791-1. [2] XUE C, YAO Q, GU X, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer[J/OL]. Signal Transduction and Targeted Therapy, 2023, 8(1): 204. DOI:10.1038/s41392-023-01468-7. |
» ²ÂÄãϲ»¶
ÃÚÄòϵͳģÐÍ
ÒѾÓÐ0È˻ظ´
±½·ÓÁòËá·¨²â´Ö¶àÌÇ
ÒѾÓÐ1È˻ظ´
΢ÉúÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ82È˻ظ´
¼ì²âµ°°×Öʾ«°±Ëá¼×»ù»¯µÄ¿¹ÌåÑ¡Äĸö£¿
ÒѾÓÐ0È˻ظ´
¶þ·úÒÒËáÒÒõ¥»¹Ô³É¶þ·úÒÒÈ©Ëõ°ëÒÒ´¼
ÒѾÓÐ7È˻ظ´
ÉϺ£½»Í¨´óѧÁè´úË´½ÌÊÚ/ɽÎ÷Ò½¿Æ´óѧ±åΰ½ÌÊÚ ÁªºÏÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú
ÒѾÓÐ0È˻ظ´
ÈçºÎ°ÑÕâ¸ö½á¹¹ÅªÏûÐý
ÒѾÓÐ10È˻ظ´














»Ø¸´´ËÂ¥